ArticleSchizophrenia bulletin2026
Neurometabolic Differences in Psychosis Observed with 7 T Magnetic Resonance Spectroscopy.
Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAltered brain chemistry is thought to contribute to impaired cognition and perceptual functioning in people with psychotic psychopathology (PwPP). As heritable genetic factors shape the development of psychosis, alterations in brain chemistry may extend to biological relatives of PwPP. Magnetic resonance spectroscopy (MRS) is a non-invasive method for quantifying concentrations of various neurochemicals in the human brain. Previous studies using MRS have generally focused on specific diagnoses (eg, schizophrenia), rather than PwPP trans-diagnostically, and comparably few studies have examined relatives. The goal of the current study was to assess neurometabolic differences in PwPP and relatives using MRS in a large number of participants. STUDY
designAs part of the Psychosis Human Connectome Project, we acquired ultra-short echo time (8 ms) MRS data at 7 tesla in both occipital and prefrontal cortices from 64 PwPP, 42 first-degree biological relatives, and 43 controls. STUDY
resultsWe observed lower levels of N-acetyl-aspartate (NAA) in the occipital lobe in PwPP and relatives versus controls, and a trend toward lower N-acetyl-aspartylglutamate in prefrontal cortex in PwPP versus controls. Lower OCC NAA levels were also evident in diagnostic subgroups of PwPP (schizophrenia and bipolar disorder) compared to controls. We also observed higher levels of glucose in both occipital and prefrontal cortices in PwPP. Hierarchical clustering analyses showed that higher glucose levels were linked to higher psychiatric symptoms, poorer cognition, and impaired visual task performance.
conclusionsTogether, our findings point to alterations in neural metabolism across multiple brain areas in PwPP that are associated with impaired cognitive and perceptual functioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.